Aug 25, 2021 08:00 AM

China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.1% in First Half of 2021

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 622.6 million yuan in the first half of 2021, up 11.1% year-on-year.

Meanwhile, the company posted 4.6 billion yuan in revenue, up 11.6% year-on-year.

At the end of the reporting period, it had 13.4 billion yuan in total assets and 3.3 billion yuan in total liabilities, with a liability-to-asset ratio of 24.6%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin China Biz Roundup: Rape Allegations at Acting School Spark Uproar